Clinical outcomes in borderline resectable pancreatic cancer (BRPC): A single institutional analysis.

Daniel Ezekwudo,Bolanle Gbadamosi,John Khoury,Leann Blankenship,Susanna S. Gaikazian,Joseph M Anderson,Michael J. Stender,Robert P. Jury,Laura Nadeau,Cotant Matthew,John M. Robertson,Jeffrey Margolis,Ishmael Jaiyesimi

Clinical outcomes in borderline resectable pancreatic cancer (BRPC): A single institutional analysis.

2018

Daniel Ezekwudo
Bolanle Gbadamosi
John Khoury
Leann Blankenship
Susanna S. Gaikazian
Joseph M Anderson
Michael J. Stender
Robert P. Jury
Laura Nadeau
Cotant Matthew
John M. Robertson
Jeffrey Margolis
Ishmael Jaiyesimi

e16232Background: Neoadjuvant therapy in BRPC serve to improve margin negative resection rate, however emerging data indicate otherwise. Aim of the study is to retrospectively investigate the clini...

Keywords:

Physical therapy
Oncology
Internal medicine
Resectable Pancreatic Cancer
Medicine
Neoadjuvant therapy
Pancreatic cancer
borderline resectable
Resection

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations